Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/16/2022 | Lyell Immunopharma, Inc. | LYEL | Grant | Option (right to buy) | 300k | $5.98 | $1.8M | | 03/16/2022 |
02/25/2019 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right-to-Buy) | 115.5k | $9.03 | $1M | | 02/25/2019 |
02/25/2019 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 19.2k | $0.00 | $0 | | 02/25/2019 |
02/28/2018 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 200k | $23.95 | $4.8M | | 02/28/2018 |
02/09/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 1.6k | $41.69 | $65.1k | | 02/09/2018 |
02/09/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 600 | $40.62 | $24.4k | | 02/09/2018 |
02/09/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 733 | $39.66 | $29.1k | | 02/09/2018 |
02/09/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 600 | $38.63 | $23.2k | | 02/09/2018 |
02/09/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 4.1k | $37.38 | $154.1k | | 02/09/2018 |
02/09/2018 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 4.6k | $36.63 | $168.4k | | 02/09/2018 |
02/06/2018 | Atara Biotherapeutics, Inc. | ATRA | Payment of Exercise | Common Stock | 4.4k | $35.80 | $158.7k | | 02/06/2018 |
02/09/2017 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 633 | $16.16 | $10.2k | | 02/09/2017 |
02/09/2017 | Atara Biotherapeutics, Inc. | ATRA | Sale | Common Stock | 11.6k | $15.70 | $181.8k | | 02/09/2017 |
02/06/2017 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 49.5k | $0.00 | $0 | | 02/06/2017 |
09/22/2016 | Atara Biotherapeutics, Inc. | ATRA | Grant | Employee Stock Option (Right to Buy) | 40k | $20.46 | $818.4k | | 09/22/2016 |
02/09/2016 | Atara Biotherapeutics, Inc. | ATRA | Grant | Common Stock | 48.9k | $0.00 | $0 | | 02/09/2016 |
12/17/2015 | Atara Biotherapeutics, Inc. | ATRA | Grant | Employee Stock Option (Right to Buy) | 65k | $22.72 | $1.5M | | 12/17/2015 |
08/03/2015 | Atara Biotherapeutics, Inc. | ATRA | Grant | Employee Stock Option (Right to Buy) | 130k | $56.98 | $7.4M | | 08/03/2015 |
02/03/2015 | Orexigen Therapeutics, Inc. | OREXQ | Grant | Stock Option (right to buy) | 153k | $5.34 | $817.3k | | 02/03/2015 |
12/02/2014 | Orexigen Therapeutics, Inc. | OREXQ | Sale | Common Stock | 22.6k | $6.00 | $135.9k | | 12/03/2014 |
12/02/2014 | Orexigen Therapeutics, Inc. | OREXQ | Exercise | Stock Option (right to buy) | 22.6k | $1.66 | $37.6k | | 12/03/2014 |
11/25/2014 | Orexigen Therapeutics, Inc. | OREXQ | Sale | Common Stock | 7.4k | $6.00 | $44.3k | | 11/24/2014 |
11/25/2014 | Orexigen Therapeutics, Inc. | OREXQ | Exercise | Stock Option (right to buy) | 7.4k | $1.66 | $12.3k | | 11/24/2014 |
11/24/2014 | Orexigen Therapeutics, Inc. | OREXQ | Exercise | Stock Option (right to buy) | 24k | $1.66 | $39.8k | | 11/24/2014 |
11/24/2014 | Orexigen Therapeutics, Inc. | OREXQ | Sale | Common Stock | 24k | $5.77 | $138.6k | | 11/24/2014 |
09/22/2014 | Orexigen Therapeutics, Inc. | OREXQ | Sale | Common Stock | 300k | $4.47 | $1.3M | | 09/22/2014 |
09/22/2014 | Orexigen Therapeutics, Inc. | OREXQ | Exercise | Stock Option (right to buy) | 300k | $1.66 | $498k | | 09/22/2014 |
02/07/2014 | Orexigen Therapeutics, Inc. | OREXQ | Grant | Stock Option (right to buy) | 205k | $6.30 | $1.3M | | 02/07/2014 |
11/29/2013 | Orexigen Therapeutics, Inc. | OREXQ | Grant | Common Stock | 4k | $5.34 | $21.3k | | 02/07/2014 |
07/25/2011 | Orexigen Therapeutics, Inc. | OREXQ | Grant | Stock Option (right to buy) | 1.1M | $1.66 | $1.8M | | 07/22/2011 |
07/22/2011 | Orexigen Therapeutics, Inc. | OREXQ | Disposition | Stock Option (right to buy) | 130k | $15.45 | $2M | | 07/22/2011 |
07/22/2011 | Orexigen Therapeutics, Inc. | OREXQ | Disposition | Stock Option (right to buy) | 16k | $14.26 | $228.2k | | 07/22/2011 |
07/22/2011 | Orexigen Therapeutics, Inc. | OREXQ | Disposition | Stock Option (right to buy) | 100k | $11.34 | $1.1M | | 07/22/2011 |
07/22/2011 | Orexigen Therapeutics, Inc. | OREXQ | Disposition | Stock Option (right to buy) | 39k | $4.03 | $157k | | 07/22/2011 |
07/22/2011 | Orexigen Therapeutics, Inc. | OREXQ | Disposition | Stock Option (right to buy) | 91.4k | $2.13 | $194.8k | | 07/22/2011 |
|